News

Clínic Barcelona

Research January 19 2023

Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes: new senior group leaders (R4) of IDIBAPS

IDIBAPS’s Board of Governors has approved the promotion of Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes from Junior Group Leaders t1

Clínic Barcelona

Institutional July 22 2022

Representatives of the Spanish Association Against Cancer visit IDIBAPS

The activity, which is part of a new communication project, allowed visitors to learn about the cancer research carried out by the Institute's resear1

Clínic Barcelona

Research June 16 2022

EMERALD, the first European-wide PhD program for medical doctors, opens 2nd call for applications

The deadline for applications is the 28th August and 2 of the 15 fellows will be hired by IDIBAPS.

Clínic Barcelona

Teaching and Training January 12 2022

Do you want to do your doctoral thesis at IDIBAPS?

Ten IDIBAPS groups are looking for candidates to apply for one of the 35 pre-doctoral scholarships offered by the INPhINIT Incoming program of the La1

Clínic Barcelona

Research December 17 2021

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1

2 3

page1
page2 , current page.
page3

News

Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes: new senior group leaders (R4) of IDIBAPS

Representatives of the Spanish Association Against Cancer visit IDIBAPS

EMERALD, the first European-wide PhD program for medical doctors, opens 2nd call for applications

Do you want to do your doctoral thesis at IDIBAPS?

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

navigation between pages below